CGEM
Cullinan Therapeutics Inc.
Company Overview
| Mkt Cap | $366.26M | Price | $8.66 |
| Volume | 1.84M | Change | +14.55% |
| P/E Ratio | -2.2 | Open | $7.82 |
| Revenue | -- | Prev Close | $7.56 |
| Net Income | $-167.4M | 52W Range | $5.68 - $17.50 |
| Div Yield | N/A | Target | $26.88 |
| Overall | 58 | Value | 60 |
| Quality | 31 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyCullinan Therapeutics Inc. (CGEM) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $8.66 with a market capitalization of $366.26 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CGEM with a volume of 1.84 million shares. The stock opened up 3.44% from yesterday's close of $7.56. Current analyst estimates project earnings of $-3.83 per share for this year, with next year targeting $-3.64.
CGEM demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including FBEC, BEVFF, MDLH, FVPI.
Key investment considerations for CGEM include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 210.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:40 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEM | $8.66 | +14.6% | 1.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cullinan Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW